Discover 172 paid clinical trials in Burlington, Vermont. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 172
Active & Responsive
Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response
for
Primary Central Nervous System Lymphoma
Location: 5 recruiting locations
Sponsor: Providence Health & Services
Sex: All
Age: 18+
Code: NCT06175000
Phase2, Recruiting
Active & Responsive
IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)
for
Nontuberculous Mycobacterium Infection
Location: 10 recruiting locations
Sponsor: Chris Goss
Sex: All
Age: 18+
Code: NCT04294043
Phase1, Recruiting
Active & Responsive
Nicotine Regulation for Dual Users of E-cigarettes and Cigarettes
for
Tobacco Use Disorder
Location: 2 recruiting locations
Sponsor: University of Vermont
Sex: All
Age: 21+
Code: NCT06614504
Phase2, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)
for
Calcific Aortic Valve Disease
Location: 24 recruiting locations
Sponsor: REDNVIA Co., Ltd.
Sex: All
Age: 35+
Code: NCT05143177
Phase2, Phase3, Recruiting
Active & Responsive
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
for
Generalized Myasthenia Gravis
Location: 14 recruiting locations
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Sex: All
Age: 18+
Code: NCT06463587
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
for
Hypothyroidism
Location: 109 recruiting locations
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT06345339
Phase2, Phase3, Recruiting
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease